Skip to main content
. Author manuscript; available in PMC: 2024 Jan 5.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2023 Jul 5;32(7):976–985. doi: 10.1158/1055-9965.EPI-23-0102

Table 4.

Unadjusted geometric mean hormone levels by components of lifetime ovulatory years quartile in postmenopausal women not using hormone therapy at the time of blood draw in the Nurses’ Health Study (n=1976)

Estradiol (pg/mL) Estrone (pg/mL) Estrone sulfate (pg/mL) Testosterone (ng/dL) DHEAS (ug/dL) Prolactin (ng/mL) SHBG (nmol/L)
N Mean (95% CI) N Mean (95% CI) N Mean (95% CI) N Mean (95% CI) N Mean (95% CI) N Mean (95% CI) N Mean (95% CI)
Age at menarche
 <12 347 5.5 (5.2–5.8) 323 23.6 (22.4–24.8) 260 244.1 (224.1–265.8) 402 19.7 (18.8–20.7) 282 59.8 (54.9–65.1) 264 8.9 (8.4–9.4) 383 55.1 (52.4–58.0)
 12 408 5.3 (5.0–5.6) 391 23.3 (22.2–24.5) 303 233.9 (215.0–254.5) 468 20.0 (19.1–20.9) 334 59.8 (55.1–65.0) 298 9.0 (8.6–9.4) 447 55.4 (53.0–58.0)
 13 498 5.1 (4.9–5.4) 468 22.5 (21.5–23.4) 345 228.3 (212.6–245.1) 554 19.9 (19.1–20.8) 402 55.2 (51.4–59.4) 344 9.0 (8.6–9.4) 533 56.1 (53.7–58.6)
 14 227 5.1 (4.8–5.5) 221 22.2 (20.9–23.6) 169 221.1 (201.5–242.6) 268 19.9 (18.7–21.1) 214 58.1 (52.8–64.0) 173 8.8 (8.2–9.5) 250 56.3 (53.0–59.8)
 >14 144 4.7 (4.3–5.1) 133 21.7 (20.1–23.4) 105 227.1 (198.8–259.4) 177 19.3 (17.8–21.0) 142 54.6 (48.4–61.6) 113 8.9 (8.2–9.7) 166 59.8 (55.0–65.0)
 ANOVA p-value 0.04 0.27 0.64 0.96 0.45 0.99 0.50
Age at menopause
 <48 240 5.3 (4.9–5.6) 225 22.8 (21.5–24.3) 173 250.5 (225.9–277.7) 280 20.0 (18.9–21.2) 200 66.6 (60.1–73.8) 179 9.2 (8.5–9.9) 269 57.0 (53.6–60.7)
 48–49 246 4.8 (4.5–5.2) 236 21.9 (20.7–23.1) 191 211.3 (192.1–232.5) 287 19.9 (18.9–21.1) 213 62.6 (56.8–69.1) 187 8.7 (8.2–9.3) 272 61.5 (58.0–65.3)
 50–51 564 5.1 (4.9–5.3) 533 22.6 (21.7–23.5) 403 215.0 (201.1–229.9) 648 19.2 (18.4–20.0) 484 54.1 (50.6–57.7) 409 8.9 (8.5–9.3) 619 57.5 (55.3–59.7)
 >51 574 5.5 (5.2–5.7) 542 23.4 (22.5–24.4) 415 252.4 (235.9–270.0) 654 20.3 (19.5–21.1) 477 55.8 (52.1–59.7) 417 9.0 (8.6–9.4) 619 52.1 (50.0–54.3)
 ANOVA p-value 0.02 0.28 0.008 0.22 0.002 0.76 <0.0001
OC use
 No 1107 5.3 (5.1–5.4) 1052 23.0 (22.3–23.6) 779 229.0 (218.1–240.4) 1257 20.3 (19.7–20.9) 929 55.6 (53.1–58.3) 784 9.1 (8.8–9.4) 1200 56.3 (54.7–58.0)
 Yes 511 5.1 (4.9–5.4) 479 22.5 (21.5–23.4) 398 238.6 (223.0–255.3) 605 18.9 (18.1–19.7) 441 61.8 (57.5–66.3) 403 8.6 (8.2–8.9) 572 55.5 (53.3–57.8)
 t-test p-value 0.35 0.40 0.33 0.004 0.01 0.03 0.58
Duration of OC use
 ≤0.5 101 4.9 (4.4–5.5) 97 21.9 (19.8–24.3) 76 222.8 (189.4–262.0) 121 19.4 (17.5–21.5) 83 59.8 (50.1–71.4) 81 8.6 (7.9–9.3) 116 56.3 (51.5–61.5)
 >0.5–3 140 5.2 (4.7–5.8) 129 22.9 (21.0–25.0) 118 244.0 (214.9–277.1) 168 19.1 (17.5–20.8) 125 58.0 (50.4–66.7) 115 8.3 (7.6–9.0) 160 54.6 (50.7–58.7)
 >3–8 131 5.2 (4.8–5.7) 122 22.3 (20.5–24.2) 91 239.4 (210.7–272.1) 154 18.9 (17.5–20.5) 114 68.2 (60.4–77.1) 97 8.5 (7.9–9.2) 147 54.3 (49.9–59.1)
 >8 117 5.1 (4.6–5.6) 111 22.6 (20.6–24.8) 99 244.6 (210.9–283.7) 132 18.0 (16.7–19.5) 96 60.1 (51.1–70.7) 95 9.0 (8.2–9.9) 124 55.8 (51.3–60.6)
 ANOVA p-value 0.84 0.92 0.80 0.69 0.39 0.60 0.92
Parity
 Nulliparous 75 5.3 (4.6–6.0) 74 23.0 (20.6–25.7) 50 261.4 (211.9–322.4) 81 21.0 (18.6–23.8) 58 62.0 (51.6–74.4) 50 8.7 (8.0–9.5) 79 60.2 (53.8–67.3)
 Parous 1549 5.2 (5.1–5.3) 1462 22.8 (22.3–23.4) 1132 230.7 (221.6–240.2) 1788 19.8 (19.3–20.2) 1316 57.4 (55.2–59.8) 1142 8.9 (8.7–9.2) 1700 55.9 (54.6–57.2)
 t-test p-value 0.81 0.87 0.21 0.28 0.45 0.55 0.20
Parity
 1–2 462 5.3 (5.0–5.6) 439 23.3 (22.3–24.4) 333 240.0 (221.7–259.9) 513 20.9 (20.0–21.9) 379 62.7 (58.0–67.8) 331 9.4 (8.9–9.9) 497 55.0 (52.5–57.5)
 3 394 5.2 (4.9–5.4) 371 22.5 (21.5–23.6) 292 243.0 (225.7–261.7) 477 20.0 (19.1–20.9) 352 56.1 (51.9–60.6) 300 8.9 (8.4–9.3) 448 55.4 (52.9–58.0)
 4 355 5.1 (4.8–5.5) 330 22.6 (21.5–23.7) 252 227.9 (209.1–248.4) 410 19.0 (18.1–20.0) 300 55.8 (51.4–60.5) 265 8.9 (8.4–9.4) 397 56.6 (53.9–59.5)
 >4 338 5.2 (4.9–5.5) 322 22.6 (21.5–23.8) 255 209.0 (192.5–226.8) 388 18.8 (17.9–19.8) 285 54.4 (49.8–59.3) 246 8.6 (8.1–9.1) 358 56.9 (54.0–60.0)
 ANOVA p-value 0.83 0.66 0.04 0.007 0.05 0.10 0.71
Breastfeeding
 No 563 5.3 (5.0–5.5) 532 23.3 (22.4–24.2) 411 231.9 (216.7–248.1) 663 20.4 (19.6–21.2) 488 56.5 (53.0–60.3) 422 9.2 (8.8–9.6) 630 56.3 (54.2–58.6)
 Yes 1061 5.2 (5.0–5.3) 1004 22.5 (21.9–23.2) 771 232.0 (221.0–243.5) 1206 19.5 (19.0–20.1) 886 58.2 (55.4–61.2) 770 8.8 (8.5–9.1) 1149 55.9 (54.3–57.6)
 t-test p-value 0.44 0.18 0.99 0.09 0.48 0.08 0.76
Months breastfed
 ≤3 450 5.2 (4.9–5.4) 423 22.7 (21.7–23.8) 326 225.0 (208.2–243.1) 510 19.6 (18.8–20.6) 362 59.8 (55.4–64.6) 329 8.7 (8.3–9.1) 492 56.1 (53.7–58.6)
 4–11 328 5.1 (4.8–5.4) 311 22.3 (21.1–23.5) 243 236.0 (217.6–256.1) 374 19.1 (18.1–20.1) 282 57.4 (52.6–62.6) 244 8.5 (8.1–9.0) 357 56.5 (53.6–59.6)
 ≥12 283 5.2 (4.9–5.6) 270 22.6 (21.3–23.9) 202 238.8 (216.7–263.1) 322 19.8 (18.7–21.0) 242 56.9 (51.7–62.7) 197 9.2 (8.6–9.9) 300 54.9 (51.7–58.4)
 ANOVA p-value 0.86 0.86 0.56 0.60 0.68 0.17 0.77
Ovulatory years
 <29.8 403 5.0 (4.8–5.3) 381 21.9 (20.9–23.0) 313 230.3 (213.4–248.7) 470 18.5 (17.7–19.4) 347 59.7 (55.2–64.6) 312 8.4 (8.0–8.9) 445 57.7 (55.0–60.5)
 29.8–33.0 408 5.0 (4.7–5.2) 392 22.4 (21.4–23.5) 296 226.2 (210.2–243.3) 478 19.6 (18.8–20.5) 355 58.4 (54.1–63.0) 301 9.2 (8.7–9.7) 451 57.9 (55.4–60.5)
 33.1–35.9 392 5.3 (5.0–5.6) 365 23.1 (22.0–24.3) 269 223.5 (205.4–243.1) 442 20.6 (19.6–21.6) 323 55.4 (51.1–60.1) 278 9.1 (8.6–9.5) 422 56.7 (53.9–59.6)
 ≥36.0 421 5.5 (5.2–5.8) 398 23.8 (22.7–24.9) 304 247.4 (227.8–268.7) 479 20.6 (19.7–21.6) 349 56.9 (52.7–61.5) 301 9.1 (8.7–9.6) 461 52.3 (50.0–54.8)
 ANOVA p-value 0.02 0.09 0.28 0.004 0.59 0.05 0.007